Old Mission Capital’s Amedisys AMED Stock Holding History

Old Mission Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,839	Closed	-$1.02M	–	1011
2021 Q1	$1.02M	Sell	3,839 -273	-7%	-$77K	0.06%	358
2020 Q4	$1.21M	Buy	+4,112	New	+$1.05M	0.07%	211

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Old Mission Capital's AMED Position: Q2 2021 in Review

Old Mission Capital sold out of Amedisys (AMED) in Q2 2021, closing a stake of 3,839 shares — an estimated $1.02M sold.

Old Mission Capital first reported a position in AMED in Q4 2020 and held it in 2 quarters. The position peaked at $1.21M in Q4 2020. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

Old Mission Capital reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
Old Mission Capital sold 3,839 Amedisys shares in Q2 2021, an estimated $1.02M.
Old Mission Capital first reported a position in Amedisys in Q4 2020 and held it in 2 quarters.
Old Mission Capital's Amedisys position peaked at $1.21M in Q4 2020.
375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Old Mission Capital's 13F filing for Q2 2021, filed 13 Aug 2021.